InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.550 0.015 (2.80%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$150 Quarterly Activity Report & Appendix 4C 17 Oct 2023 9:51AM $0.355 $0.550 risen by 54.93%
$150 Notification of cessation of securities - OCC 9 Oct 2023 8:40AM $0.350 $0.550 risen by 57.14%
$150 Final Director's Interest Notice 2 Oct 2023 8:54AM $0.375 $0.550 risen by 46.67%
$150 Proposed issue of securities - OCC 27 Sep 2023 1:03PM $0.375 $0.550 risen by 46.67%
$150 Annual Report to Shareholders 27 Sep 2023 12:36PM $0.375 $0.550 risen by 46.67%
$150 Notice of Annual General Meeting/Proxy Form 27 Sep 2023 12:33PM $0.375 $0.550 risen by 46.67%
$150 Letter to Shareholders - Annual General Meeting 27 Sep 2023 12:30PM $0.375 $0.550 risen by 46.67%
$150 Final Director's Interest Notice 22 Sep 2023 9:41AM $0.375 $0.550 risen by 46.67%
$150 Orthocell Board Changes 22 Sep 2023 9:37AM $0.375 $0.550 risen by 46.67%
$150 Date of AGM & Closing Date for Director Nominations 4 Sep 2023 8:54AM $0.380 $0.550 risen by 44.74%
$150 Appendix 4G 31 Aug 2023 3:51PM $0.405 $0.550 risen by 35.80%
$150 Corporate Governance Statement 31 Aug 2023 3:50PM $0.405 $0.550 risen by 35.80%
$150 Appendix 4E & Annual Report 31 Aug 2023 3:50PM $0.405 $0.550 risen by 35.80%
$150 Striate re-certified under new European medical device regs 24 Aug 2023 9:13AM $0.380 $0.550 risen by 44.74%
$150 Quarterly Activity Report & Appendix 4C 31 Jul 2023 8:56AM $0.395 $0.550 risen by 39.24%
$150 Orthocell receives A$3.17m R&D tax incentive refund 21 Jun 2023 9:00AM $0.350 $0.550 risen by 57.14%
$150 Change of Director's Interest Notice - Paul Anderson 16 Jun 2023 9:08AM $0.345 $0.550 risen by 59.42%
$150 Change of Director's Interest Notice - Paul Anderson 13 Jun 2023 9:25AM $0.355 $0.550 risen by 54.93%
$150 Initial Director's Interest Notice - John Van Der Wielen 1 Jun 2023 4:18PM $0.375 $0.550 risen by 46.67%
$150 Proposed issue of securities - OCC 29 May 2023 9:45AM $0.365 $0.550 risen by 50.68%
$150 Notification regarding unquoted securities - OCC 29 May 2023 9:40AM $0.365 $0.550 risen by 50.68%
$150 John Van Der Wielen appointed Independent Non-Exec Chair 29 May 2023 9:13AM $0.365 $0.550 risen by 50.68%
$150 Option Terms and Conditions 26 May 2023 8:30AM $0.345 $0.550 risen by 59.42%
$150 Notification regarding unquoted securities - OCC 26 May 2023 8:27AM $0.345 $0.550 risen by 59.42%
$150 Quarterly Activity Report & Appendix 4C 27 Apr 2023 9:03AM $0.400 $0.550 risen by 37.50%

276 - 300 of 775 results

Page 12 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.